Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors

Published:2015-10 Issue:10 Volume:47 Page:869-876
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Nault Jean-Charles,Pigneur Frédéric,Nelson Anaïs Charles,Costentin Charlotte,Tselikas Lambros,Katsahian Sandrine,Diao Guoqing,Laurent Alexis,Mallat Ariane,Duvoux Christophe,Luciani Alain,Decaens Thomas

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design;Llovet;Clinical Cancer Research,2014

3. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study;Johnson;Journal of Clinical Oncology,2013

4. SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma;Zhu;Journal of Clinical Oncology,2014

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;Journal of Hepatology,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib;Cancers;2024-03-07

3. The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib;Cancers;2024-01-20

4. Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis;European Journal of Radiology;2023-10

5. Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients;Journal of Cachexia, Sarcopenia and Muscle;2023-08-17